المؤلفون: Gunter SJ; Harvard Medical School, Boston, Massachusetts., Holcomb ZE; Section of Dermatology, Department of Medicine, Carilion Clinic, Roanoke, Virginia., Lam BD; Division of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Porter ML; Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Department of Dermatology, Harvard Medical School, Boston, Massachusetts., Kimball AB; Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.

المصدر: JAMA dermatology [JAMA Dermatol] 2024 Jun 01; Vol. 160 (6), pp. 678-681.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Hidradenitis Suppurativa*/drug therapy , Adalimumab*/adverse effects , Adalimumab*/therapeutic use , Adalimumab*/administration & dosage, Humans ; Female ; Male ; Adult ; Middle Aged ; Hematologic Diseases ; Anti-Inflammatory Agents/therapeutic use ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/adverse effects

المؤلفون: Gunter SJ; Harvard Medical School, Boston, Massachusetts, USA., Kim EJ; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: Ellen.Kim@pennmedicine.upenn.edu.

المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2024 Apr; Vol. 144 (4), pp. 855-861.e1. Date of Electronic Publication: 2023 Nov 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Sezary Syndrome*/drug therapy , Skin Neoplasms*/diagnosis , Skin Neoplasms*/drug therapy , Mycosis Fungoides*/diagnosis , Mycosis Fungoides*/drug therapy , Lymphoma, T-Cell, Cutaneous*/drug therapy, Humans ; Retrospective Studies

المؤلفون: Rome BN; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Gunter SJ; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.

المصدر: Health services research [Health Serv Res] 2023 Aug; Vol. 58 (4), pp. 953-959. Date of Electronic Publication: 2023 Mar 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Blackwell Country of Publication: United States NLM ID: 0053006 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1475-6773 (Electronic) Linking ISSN: 00179124 NLM ISO Abbreviation: Health Serv Res Subsets: MEDLINE

مواضيع طبية MeSH: Medicaid* , Prescription Drugs*, United States ; Humans ; Cross-Sectional Studies ; Drug Costs

المؤلفون: Mitra-Majumdar M; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Gunter SJ; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Brown BL; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Joyce KW; Kaiser Permanente Institute for Health Policy, Oakland, California., Ross M; Kaiser Permanente Institute for Health Policy, Oakland, California., Pham C; Kaiser Permanente National Pharmacy, Downey, California., Avorn J; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Darrow JJ; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Law and Taxation, Bentley University, Waltham, Massachusetts.

المصدر: JAMA network open [JAMA Netw Open] 2022 May 02; Vol. 5 (5), pp. e2212454. Date of Electronic Publication: 2022 May 02.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Drug Approval*/methods, Cohort Studies ; Humans ; Pharmaceutical Preparations ; United States ; United States Food and Drug Administration

المؤلفون: Gunter SJ; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Rome BN; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.

المصدر: JAMA internal medicine [JAMA Intern Med] 2022 Mar 01; Vol. 182 (3), pp. 342-345.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Drug Approval* , Medicaid*, Drug Costs ; Drugs, Generic ; Humans ; Pharmaceutical Preparations ; United States ; United States Food and Drug Administration

المؤلفون: Gunter SJ; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Kesselheim AS; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Rome BN; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.

المصدر: JAMA internal medicine [JAMA Intern Med] 2021 Aug 01; Vol. 181 (8), pp. 1124-1126.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Drug Approval*/methods , Drug Approval*/organization & administration , Drug Industry*/economics , Drug Industry*/legislation & jurisprudence , Economic Competition*, Drug Costs/legislation & jurisprudence ; Drugs, Generic/economics ; Humans ; Orphan Drug Production ; United States

المؤلفون: Cunniffe NG; Department of Clinical Neurosciences, Cambridge University, Cambridge, UK., Gunter SJ; Harvard Medical School, Harvard University, Boston, Massachusetts, USA., Brown M; Division of Infection, University College London Hospital NHS Trust, London, UK., Burge SW; Cancer Research UK Urological Malignancies Programme, Department of Oncology, University of Cambridge, Cambridge, UK., Coyle C; Department of Cardiology, Hammersmith Hospitals NHS Trust, London, UK., De Soyza A; Respiratory Medicine, Freeman Hospital, Newcastle upon Tyne, UK., Dymond T; Department of Infection and Inflammation Research, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Esmail H; Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, UK.; MRC Clinical Trials Unit, University College London, London, UK.; Institute for Global Health, University College London, London, United Kingdom., Francis DP; Faculty of Medicine, National Heart & Lung Institute, Imperial College London, London, UK., Galloway J; Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Galloway JB; Centre for Rheumatic Diseases, Kings College London, London, UK., Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Greenaway J; Research and Development, North Tees Hospital, Stockton-on-Tees, UK., Katritsis G; National Heart and Lung Institute, Imperial College London, London, UK., Kanagaratnam P; Department of Cardiology, St Marys Hospital, Imperial College Healthcare NHS Trust, London, UK., Knolle MD; Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Leonard K; Cambridge Urology Translational Research and Clinical Trials Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., McIntyre ZC; School of Clinical Medicine, Office for Translational Research, University of Cambridge, Cambridge, UK., Prudon B; Department of Respiratory Medicine, North Tees Hospital, Stockton-on-Tees, UK., Rampling T; Division of Pathology, University College London Hospital NHS Trust, London, United Kingdom., Torok ME; University of Cambridge, Cambridge, UK., Warne B; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK., Yates M; Centre for Rheumatic Diseases, Kings College London, London, UK., Matheson NJ; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.; NHS Blood and Transplant, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Su L; MRC Biostatistics Unit, University of Cambridge School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom., Villar S; MRC Biostatistics Unit, University of Cambridge School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom., Stewart GD; Cancer Research UK Urological Malignancies Programme, Department of Oncology, University of Cambridge, Cambridge, UK.; Department of Surgery, University of Cambridge, Cambridge, UK., Toshner M; Department of Medicine, University of Cambridge, Cambridge, UK mrt34@medschl.cam.ac.uk.; NIHR Respiratory Translational Research Collaboration, Cambridge, UK.

المصدر: BMJ open [BMJ Open] 2020 Oct 05; Vol. 10 (10), pp. e044566. Date of Electronic Publication: 2020 Oct 05.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Biomedical Research*/organization & administration , Biomedical Research*/statistics & numerical data , Coronavirus Infections*/epidemiology , Coronavirus Infections*/therapy , Pandemics* , Patient Selection* , Pneumonia, Viral*/epidemiology , Pneumonia, Viral*/therapy , Randomized Controlled Trials as Topic*/methods , Randomized Controlled Trials as Topic*/statistics & numerical data, Betacoronavirus/isolation & purification ; COVID-19 ; Eligibility Determination ; Female ; Health Services Accessibility/statistics & numerical data ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Prospective Studies ; Registries/statistics & numerical data ; SARS-CoV-2 ; United Kingdom